| [1]黄建萍,茆汉梅,糜跃萍,等.南通市2007—2010年心脑血管疾病死因分析[J].中国卫生统计,2013,30(1):100-101.
HUANG J P,MAO H M,MI Y P,et al.Analysis on the cause of death of cardiovascular and cerebrovascular diseases in Nantong City during 2007—2010[J].Chinese Journal of Health Statistics,2013,30(1):100-101.
[2]谭学君.心脑血管疾病的危险因素及预防方法分析[J].现代诊断与治疗,2014,21(7):1604-1605.
TAN X J.Analysis on the risk factors and prevention methods of cardiovascular and cerebrovascular diseases[J].Mod Diagn Treat,2014,21(7):1604-1605.
[3]李秀清.心脑血管疾病的危险因素及预防方法分析[J].亚太传统医药,2012,8(1):179-181.
LI X Q.Analysis on the risk factors and prevention methods of cardiovascular and cerebrovascular diseases[J].Asia-Pacific Traditional Medicine,2012,8(1):179-181.
10.3969/j.issn.1673-2197.2012.01.098.
[4]AGABITI R E,MANCIA G,O’ROURKE M F,et al.Central blood pressure measurements and antihypertensive therapy:a consensus document[J].Hypertension,2007,50(1):154-160.
[5]SHAHABI V,MOAZENZADEH M,AZIMZADEH B S,et al.Relationship between serum N-terminal pro brain natriuretic peptide(NT-ProBNP) level and the severity of coronary artery involvements[J].J Res Med Sci,2011,16(2):143-148.
[6]中华医学会心血管病学分会介入心脏病学组,中华心血管病杂志编辑委员会.中国经皮冠状动脉介入治疗指南2012[J].中华危重症医学杂志,2012,5(3):169-180.
Cardiology Interventional Cardiology Group of Chinese Medical Association,Editorial Committee of Chinese Journal of Cardiology.Guidelines for percutaneous coronary intervention in China 2012[J].Chin J Crit Care Med,2012,5(3):169-180.
[7]FIHN S D,GARDIN J M,ABRAMS J,et al.2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease:executive summary:a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines,and the American College of Physicians,American Association for Thoracic Surgery,Preventive Cardiovascular Nurses Association,Society for Cardiovascular Angiography and Interventions,and Society of Thoracic Surgeons[J].Circulation,2012,126(25):3097-3137.
[8]Task Force Members,MONTALESCOT G,SECHTEM U,et al.2013 ESC guidelines on the management of stable coronary artery disease:the Task Force on the management of stable coronary artery disease of the European Society of Cardiology[J].Eur Heart J,2013,34(38):2949-3003.
[9]ZHENG J L,LU L,HU J,et al.Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease[J].Atherosclerosis,2010,210(2):590-595.
[10]牛方清,刘伟昌,窦晋景.NT-proBNP与超敏C反应蛋白在心衰患者中的相关性研究[J].医学理论与实践,2013,26(2):143-144.
NIU F Q,LIU W C,DOU J J.Investigation about the relativity between N-terminal pro-brain natriuretic peptide and high sensitive C-relative protein in patients with heart failure[J].J Med Theor & Prac,2013,26(2):143-144.
[11]武春燕,王桂红,刘玫,等.BNP联合cTn-I对急性心肌梗死的诊断价值[J].中西医结合心脑血管病杂志,2013,11(1):122.
WU C Y,WANG G H,LIU M,et al.Value of BNP combined with cTn-I in the diagnosis of acute myocardial infarction[J].Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular,2013,11(1):122.
10.3969/j.issn.1672-1349.2013.01.070.
[12]李杰.急性冠脉综合征患者血清BNP水平与冠状动脉病变关系研究[J].中国医药科学,2013,3(2):121.
LI J.Study on the relationship between serum BNP levels of patients with acute coronary ayndrome and coronary artery lesions[J].China Medicine and Phamacy,2013,3(2):121.
[13]林艳丽,徐裔婷,傅雷,等.急性心肌梗死患者CRP、NT-proBNP和血脂的变化[J].放射免疫学杂志,2013,26(1):33-34.
LIN Y L,XU Y T,FU L,et al.Changes of CRP,NT-proBNP and serum lipids in patients with acute myocardial infarction[J].Journal of Radioimmunology,2013,26(1):33-34.
10.3969/j.issn.108-9810.2013.01.015.
[14]HOLMES R S,VAUGHAN T L.Epidemiology and pathogenesis of esophageal cancer[J].Semin Radiat Oncol,2007,17(1):2-9.
[15]MCENIERY C M,YASMIN M C,DONNELL B,et al.Central pressure:variaility and impact of cardiovascular risk factors:the anglo-cardiff collaborative trial II[J].Hypertension,2008,51(6):1476-1482.
[16]ROMAN M J,DEVEREUX R B,KIZER J R,et al.High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study[J].J Am Coll Cardiol,2009,54(18):1730-1734.
[17]ROMAN M J,DEVEREUX R B,KIZER J R,et al.Central pressure more strongly relates to vascular disease and outcome than does brachial pressure:the Strong Heart Study[J].Hypertension,2007,50(1):197-203.
[18]AGABITI R E,MANCIA G,O’ROURKE M F,et al.Central blood pressure measurements and antihypertensive therapy:a consensus document[J].Hypertension,2007,50(1):154-160.
[19]LAWES C M,VANDER H S,RODGERS A.Global burden of blood-pressure-related disease,2001[J].Lancet,2008,371(9623):1513-1518.
[20]王喆.《中国心力衰竭诊断和治疗指南2014》解读[J].中国临床医生杂志,2016,44(5):14-16.
WANG Z.Interpretation of guidelines for the diagnosis and treatment of heart failure in China 2014[J].Chin J Clinicians,2016,44(5):14-16.
10.3969/j.issn.2095-8552.2016.05.006.
[21]王恺皞,蒋雄京.年轻单纯收缩期高血压患者中心动脉压测量的特殊意义[J].中华高血压杂志,2016,24(2):132-134.
WANG K H,JIANG X J.Special significance of the measurement of central arterial pressure in young patients with simple systolic hypertension[J].Chin J Hypertens,2016,24(2):132-134. |